BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Faïon L, Djaout K, Frita R, Pintiala C, Cantrelle FX, Moune M, Vandeputte A, Bourbiaux K, Piveteau C, Herledan A, Biela A, Leroux F, Kremer L, Blaise M, Tanina A, Wintjens R, Hanoulle X, Déprez B, Willand N, Baulard AR, Flipo M. Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening. Eur J Med Chem 2020;200:112440. [PMID: 32505086 DOI: 10.1016/j.ejmech.2020.112440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Perveen S, Sharma R. Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery. Biochem Pharmacol 2022;197:114906. [PMID: 34990594 DOI: 10.1016/j.bcp.2021.114906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 de Esch IJP, Erlanson DA, Jahnke W, Johnson CN, Walsh L. Fragment-to-Lead Medicinal Chemistry Publications in 2020. J Med Chem 2021. [PMID: 34928151 DOI: 10.1021/acs.jmedchem.1c01803] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
3 Helesbeux JJ, Carro L, McCarthy FO, Moreira VM, Giuntini F, O'Boyle N, Matthews SE, Bayraktar G, Bertrand S, Rochais C, Marchand P. 29th Annual GP2A Medicinal Chemistry Conference. Pharmaceuticals (Basel) 2021;14:1278. [PMID: 34959677 DOI: 10.3390/ph14121278] [Reference Citation Analysis]
4 Deprez B, Bosc D, Charton J, Couturier C, Deprez-Poulain R, Flipo M, Leroux F, Villemagne B, Willand N. Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal Chemistry. Molecules 2021;26:6083. [PMID: 34641626 DOI: 10.3390/molecules26196083] [Reference Citation Analysis]
5 Gupta P, Thomas SE, Zaidan SA, Pasillas MA, Cory-Wright J, Sebastián-Pérez V, Burgess A, Cattermole E, Meghir C, Abell C, Coyne AG, Jacobs WR Jr, Blundell TL, Tiwari S, Mendes V. A fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis. Comput Struct Biotechnol J 2021;19:3491-506. [PMID: 34194673 DOI: 10.1016/j.csbj.2021.06.006] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Shaku M, Ealand C, Kana BD. Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets. Front Cell Infect Microbiol 2020;10:603382. [PMID: 33282752 DOI: 10.3389/fcimb.2020.603382] [Cited by in F6Publishing: 5] [Reference Citation Analysis]